Heart Groups Update Guidelines for Treating Heart Valve Disease — Physician’s First Watch

Medical News |
March 16, 2017

Heart Groups Update Guidelines for Treating Heart Valve Disease

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM

The American Heart Association and the American College of Cardiology have updated their guidelines for managing valvular heart disease. The new guidance appears in Circulation.

Here are a few of the changes since the 2014 guidelines:

  • Antibiotic prophylaxis for certain dental work is reasonable in high-risk patients, such as those with prosthetic cardiac valves or other prosthetic valve repair material.

  • Anticoagulation is recommended in those with atrial fibrillation plus a CHA2DS2-VASc score of 2 or more and who have aortic valve disease, tricuspid valve disease, or mitral regurgitation (and a vitamin K antagonist specifically for patients with rheumatic mitral stenosis).

  • Transcatheter aortic valve replacement (AVR) is a reasonable alternative to surgical AVR in symptomatic patients with severe aortic stenosis and intermediate surgical risk.

  • Patients aged 50 to 70 years have a choice of mechanical or bioprosthetic valve prosthesis, following a discussion of the risks and benefits of each.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.